Poster Session: Poster Session 1
Saturday May 04, 2019 from 18:30 to 20:00
Exhibit-Poster Area


Session Supported by


Poster Discussants
  • P.100 Non-invasive differentiation of non-rejection kidney injury from acute rejection in pediatric renal transplant recipients
    Mr. Ben Archdekin, Canada
  • P.101 Echocardiographic evaluation of cardiac function in pediatric renal patients pre and post transplantation
    Mr. Hajir Adl Golchin, Canada
  • P.102 The importance of BMP4 gene defects in renal transplant patients with CAKUT
    Prof. Esra Baskin, Turkey
  • P.103 Early post-transplant blood transfusions and graft outcome in pediatric renal transplant recipients
    Prof. Esra Baskin, Turkey
  • P.104 FSGS recurrence in pediatric renal transplants
    Tom Blydt-Hansen, Canada
  • P.105 Medical nephrectomy in children with end-stage renal disease due to nephrotic syndrome
    Dr. Charlotte M. Bootsma-Robroeks, Netherlands
  • P.106 Consequences of post-transplantation HLA antibodies for pediatric renal transplant recipients in Amsterdam
    Dr. Antonia Bouts, Netherlands
  • P.107 ESPN survey on current practice regarding recurrent focal-segmental glomerulosclerosis after pediatric kidney transplantation
    Dr. Antonia Bouts, Netherlands
  • P.108 Transport medium fluid cultures in paediatric renal transplantation: are we ready to make a consensus on prophylaxis?
    Miss Sheila Boyle, United Kingdom
  • P.109 Upside-down kidney placement: an alternative in pediatric renal transplantation
    Miss Alba Bueno, Spain
  • P.110 Long term outcomes of renal and simultaneous pancreas and kidney transplantation from paediatric donors
    Mr. Pankaj Chandak, United Kingdom
  • P.111 A Modified ‘Teach Back’ Method to Improve Health Literacy in Youth with Kidney Transplants
    Dr. Jayanthi Chandar, United States
  • P.112 Prevalence of renal dysfunction in paediatric liver transplant recipients
    Dr. Manjula Gowrishankar, Canada
  • P.113 Case report: Late-onset BK viral nephropathy with acute rejection in a paediatric kidney transplant recipient post acute obstructive uropathy in a native kidney
    Dr. Jaythoon Hassan, Ireland
  • P.114 Primary hyperoxaluria in Korea
    Prof. Hee Gyung Kang, Korea
  • P.115 Paediatric renal transplantation-Outcomes of renal allografts requiring explantation and re-implantation
    Mr. Muhammad Arslan Khurram, United Kingdom
  • P.116 The effects and consequences of blood transfusion after pediatric kidney transplantation
    Prof. Gokhan Moray, Turkey
  • P.117 Efficacy of LDL apheresis in therapy refractory recurrent FSGS
    JoAnn Morey, United States
  • P.118 High donor derived cell free DNA levels in the presence of donor specific antibodies (DSA) is a strong predictor of antibody mediated rejection (ABMR) in pediatric renal transplant recipients
    Dr. Dechu P Puliyanda, United States
  • P.119 Transplant ureterostomy in children with congenital anomalies of the kidneys and urinary tract (CAKUT)
    Dr. Tara Raftery, Ireland
  • P.120 Importance of changes to treatment plans based on pediatric renal transplant biopsy findings in Ireland: a 10-year review
    Dr. Tara Raftery, Ireland
  • P.121 Factors affecting apparent Mycophenolic Acid clearance in pediatric transplant recipients – a Retrospective Cohort Study
    Dr. Carmen I. Rodriguez Cuellar, Mexico
  • P.122 Long-term, retrospective, observational study on patient and graft survival in pediatric renal transplant recipients – Implications for the future?
    Prof. Lutz T Weber, Germany
  • P.123 Optimizing use of the UNOS policy for pediatric patients approaching ESKD
    Mrs. Melissa M Walker, United States
  • P.124 One-year outcomes of plasma cell-rich acute rejection versus acute/active antibody-mediated rejection in pediatric renal transplant recipients: A single center’s experience
    Dr. Mouin G Seikaly, United States
  • P.125 Concordance of ultrasound and magnetic resonance imaging in the vascular workup of children undergoing renal transplantation
    Dr. Stephen Marks, United Kingdom
  • P.130 A single center experience in using sirolimus in pediatric liver transplant
    Dr. Rayna Alamurova, Bulgaria
  • P.131 Initial experience with biodegradable stents for treatment of anastomotic biliary strictures in a single paediatric liver transplant center
    Dr. Rayna Alamurova, Bulgaria
  • P.132 Quadratus lumborum for fast track liver transplantation. Does it work? Is it safe?
    Dr. Daniela Damian, United States
  • P.134 Conversion to Rapamycin as a treatment modality for de-novo allergies and immune-mediated disorders Post Liver and multivisceral Transplantation
    Dr. Mohit Kehar, Canada
  • P.135 Differential post-transplant normalization rates of serum proteins in pediatric liver patients
    Dr. Richard S Mangus, United States
  • P.136 Pilot study of post liver transplant contrast enhanced ultrasound in children
    Dr. Richard S Mangus, United States
  • P.137 Short and Medium-Term Outcomes Following Percutaneous Endovascular Stent Treatment of Hepatic Venous Outflow Obstruction After Pediatric Liver Transplantation
    Dr. Eimear McGovern, United States
  • P.138 Excellent outcomes after pediatric liver transplantation for argininosuccinate lyase deficiency: A single center experience
    Prof. Patrick J. McKiernan, United States
  • P.139 Difficulties and successes with clinical research: how to convince parents to enroll their transplanted children in vaccine trials: a ten year experience
    Dr. Sébastien Papis, Switzerland
  • P.140 Management of portal vein anastomotic stenosis after pediatric liver transplantation: evaluation of single center experience
    Dr. Hubert PJ van der Doef, Netherlands
  • P.145 An exploration of health-related quality of life in pediatric renal transplant recipients
    Dr. Kaushalendra Amatya, United States
  • P.146 Social and psychological impacts of having a child with liver transplant
    Dr. Ebru H. Ayvazoglu Soy, Turkey
  • P.147 Empowering adolescents with renal transplants- what do they want?
    Dr. Helen E Jones, United Kingdom
  • P.148 The Ethics of Lung Transplant in Cystic Fibrosis
    Mrs. Dawn Freiberger, United States
  • P.149 Barriers to Pediatric Liver and Kidney Transplantation in Vietnam- a survey
    Dr. Fiona Mackie, Australia
  • P.150 Transplantation in patients with Primary Focal Segmental Glomerular Sclerosis: An ethical dilemma
    Charushree Prasad, Canada
  • P.151 Let’s Text: Engaging adolescent solid organ transplant patients to manage their health
    Dr. Steven L Rathegber, Canada
  • P.152 Substance use among adolescent solid organ transplant candidates: provider perspectives on policy
    Dr. Elizabeth A. Steinberg, United States
  • P.153 Understanding barriers and disparities in listing for pediatric solid organ transplant: patient characteristics
    Dr. Elizabeth A. Steinberg, United States
  • P.154 Exploring the chaplain’s use of "Holy Listening Stones" in pre-transplant evaluations
    Ms. Cassidy J Wohlfarth, United States
  • P.155 Transplant as Medical Trauma: Posttraumatic Growth in Pediatric Transplant Patients and Caregivers
    Dr. Kelli Triplett, United States
  • P.157 Transition of paediatric renal transplant recipients in Germany: Identifying barriers
    Dr. Lars Pape, Germany
  • P.160 Mental health and adherence following paediatric renal transplantation
    Dr. Lars Pape, Germany
  • P.161 Variability in care structures across Canadian pediatric and adult kidney, liver, and heart transplant programs
    Dr. Bethany J Foster, Canada
  • P.162 Evaluation of the Live 5-2-1-0 Healthcare Provider Toolkit in two pilot clinics at BC Children’s Hospital
    Soleina Maherali, Canada
  • P.163 Trauma-and violence-informed care with pediatric transplant patients
    Dr. Caroline Piotrowski, Canada
  • P.164 Physical Activity, Exercise Capacity, and Quality of Life in Pediatric Heart Transplant Patients
    Ms. Astrid De Souza, Canada
  • P.165 Limitations of the electronic health record on medication reconciliation
    Mrs. Kathleen Mallett, United States
  • P.166 Urinary CXCL10 stability under different sample processing conditions for use in clinical practice
    Dr. Li Wang, Canada
  • P.167 Towards gender equality: An analysis of medical and surgical publications in pediatric transplantation
    Blaire Anderson, United States
  • P.168 Sequential liver after kidney transplantation in a case of Sensenbrenner syndrome
    Prof. Joanna Pawłowska, Poland
  • P.169 Isradipine or hydralazine: Which is more cost effective and safer for the treatment of hypertension
    Katherine Twombley, United States
  • P.170 A case of hyporeninemic hypoaldosteronism following liver transplantation
    Dr. Blake J. Sandery, Canada

© 2022 IPTA 2019